The urinary levels of Th1 (IL-2, IL-12, GM-CSF, INF-γ, TNF-α) and Th2 (IL-4, IL-5, IL-10, IL-13) in FSGS and MCD patients are shown in Figure 1. This evidence concerns the gene IL13 and focal segmental glomerulosclerosis.